Australia markets open in 8 hours 55 minutes

Royalty Pharma plc (RPD.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
25.27-0.05 (-0.20%)
As of 08:01AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 11.28B
Enterprise value 15.52B
Trailing P/E 15.45
Forward P/E 9.14
PEG ratio (5-yr expected) 1.35
Price/sales (ttm)7.38
Price/book (mrq)1.91
Enterprise value/revenue 7.53
Enterprise value/EBITDA 12.30

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-17.74%
S&P500 52-week change 329.31%
52-week high 331.33
52-week low 324.58
50-day moving average 326.81
200-day moving average 326.43

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 3N/A
Shares outstanding 5450.98M
Implied shares outstanding 6590.32M
Float 8387.82M
% held by insiders 113.40%
% held by institutions 171.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.77
Forward annual dividend yield 43.05%
Trailing annual dividend rate 30.81
Trailing annual dividend yield 33.20%
5-year average dividend yield 4N/A
Payout ratio 445.51%
Dividend date 3N/A
Ex-dividend date 416 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 35.69%
Operating margin (ttm)-12.99%

Management effectiveness

Return on assets (ttm)3.54%
Return on equity (ttm)12.06%

Income statement

Revenue (ttm)2.24B
Revenue per share (ttm)4.99
Quarterly revenue growth (yoy)-17.00%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)798.86M
Diluted EPS (ttm)1.64
Quarterly earnings growth (yoy)-98.60%

Balance sheet

Total cash (mrq)872M
Total cash per share (mrq)1.93
Total debt (mrq)6.14B
Total debt/equity (mrq)62.24%
Current ratio (mrq)12.52
Book value per share (mrq)14.41

Cash flow statement

Operating cash flow (ttm)2.62B
Levered free cash flow (ttm)-1.13B